Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project
Open Access
- 19 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 44 (3), 383-395
- https://doi.org/10.1007/s40264-020-01031-1
Abstract
Introduction The public–private ADVANCE collaboration developed and tested a system to generate evidence on vaccine benefits and risks using European electronic healthcare databases. In the safety of vaccines, background incidence rates are key to allow proper monitoring and assessment. The goals of this study were to compute age-, sex-, and calendar-year stratified incidence rates of nine autoimmune diseases in seven European healthcare databases from four countries and to assess validity by comparing with published data. Methods Event rates were calculated for the following outcomes: acute disseminated encephalomyelitis, Bell’s palsy, Guillain–Barré syndrome, immune thrombocytopenia purpura, Kawasaki disease, optic neuritis, narcolepsy, systemic lupus erythematosus, and transverse myelitis. Cases were identified by diagnosis codes. Participating organizations/databases originated from Denmark, Italy, Spain, and the UK. The source population comprised all persons registered, with at least 1 year of data prior to the study start, or follow-up from birth. Stratified incidence rates were computed per database over the period 2003 to 2014. Results Between 2003 and 2014, 148,947 incident cases of nine autoimmune diseases were identified. Crude incidence rates were highest for Bell’s palsy [23.8/100,000 person-years (PYs), 95% confidence interval (CI) 23.6–24.1] and lowest for Kawasaki disease (0.7/100,000 PYs, 95% CI 0.6–0.7). Specific patterns were observed by sex, age, calendar time, and data sources. Rates were comparable with published estimates. Conclusion A range of autoimmune events could be identified in the ADVANCE system. Estimation of rates indicated consistency across selected European healthcare databases, as well as consistency with US published data.Keywords
Funding Information
- Innovative Medicines Initiative
This publication has 21 references indexed in Scilit:
- Gender-specific incidence of autoimmune diseases from national registersJournal of Autoimmunity, 2016
- Kawasaki disease incidence in children and adolescents: an observational study in primary careBritish Journal of General Practice, 2016
- Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccinesPharmacoepidemiology and Drug Safety, 2015
- Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010Eurosurveillance, 2014
- Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008–2012Zeitschrift für Neurologie, 2014
- Post-licensure rapid immunization safety monitoring program (PRISM) data characterizationVaccine, 2013
- The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaignsVaccine, 2013
- The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in EnglandVaccine, 2012
- Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilanceVaccine, 2011
- Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesThe Lancet, 2010